State Street SPDR S&P Biotech ETF (XBI) price, chart and fund profile
Price chart
Fund profile
XBI tracks an equal-weighted index of US biotechnology stocks.
- Issuer
- State Street Global Advisors
- Industry
- Healthcare
- Inception
- Jan 31, 2006
- Assets under management
- $11.5B
- Expense ratio
- 0.35%
- Net asset value
- $162.33
- NAV as of
- Aug 28, 2026
- Leverage
- 1×
- Fund page
- www.ssga.com↗
Frequently asked questions
What is State Street SPDR S&P Biotech ETF (XBI)?
XBI tracks an equal-weighted index of US biotechnology stocks.
What is XBI's expense ratio?
State Street SPDR S&P Biotech ETF charges an annual expense ratio of 0.35%. The fund is issued by State Street Global Advisors.
How large is XBI?
State Street SPDR S&P Biotech ETF manages $11.5B in assets and has traded since Jan 31, 2006.
How do I buy shares of State Street SPDR S&P Biotech ETF (XBI)?
XBI trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web dashboard at portal.lighthorse.io, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.